Pembrolizumab shows hope for cancerous gestational trophoblastic disease
An immunotherapy drug can be used to cure a rare type of cancer arising from pregnancy when existing treatments have failed...
List view / Grid view
An immunotherapy drug can be used to cure a rare type of cancer arising from pregnancy when existing treatments have failed...
Cell-weighing technique may predict which therapies a patient is most sensitive or resistant to...
A study has shown that Adipocytes can absorb and metabolise the chemotherapeutic agent daunorubicin, reducing its ability to kill cancer cells.
Proton beam therapy, in combination with chemotherapy, may be a better treatment option than traditional radiation therapy techniques...
The NIH and 11 leading biopharmaceutical companies have launched the Partnership for Accelerating Cancer Therapies (PACT), totalling $215m as part of the Cancer Moonshot....
Scientists have used genome sequencing to gain a better understanding of the biology underlying chordoma...
Breast cancer drug neratinib has been found to block the function of the Ras genes which are among the first to be linked to cancer development...
TK216-vincristine combination appears to halt the ability of Ewing sarcoma to grow and progress...
Alcohol aversion drug disulfiram may combat chemotherapy resistance in non-small cell lung cancer...
Research shows the Parkinson's disease drug carbidopa displays significant anticancer effects in human cell lines...
Researchers find ivermectin, a drug used to kill parasites, suppresses tumour development in epithelial ovarian cancer...
A genetic fault has been identified in people with an aggressive type of leukaemia that can significantly affect how they respond to treatment...
Researchers find novel combination disrupts multiple factors in aggressive breast cancer...
Taxanes inhibit cell division and make cancer cells sensitive to radiation therapy, a current study has investigated the underlying mechanisms of this action...
Adjuvant nivolumab has been found to be more superior than ipilimumab in the standard of care in patients with surgically resected stage III/IV melanoma...